Catherine C. Turkel's most recent trade in Lexaria Bioscience Corp was a trade of 1,600 common shares done at an average price of $3.1 . Disclosure was reported to the exchange on Aug. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp | Catherine C. Turkel | Director | Purchase of securities on an exchange or from another person at price $ 3.13 per share. | 12 Aug 2024 | 1,600 | 3,100 | - | 3.1 | 5,008 | common shares |
| Lexaria Bioscience Corp | Catherine C. Turkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 12,000 | 27,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Catherine C. Turkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 5,000 | 15,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Catherine C. Turkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 5,000 | 10,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Catherine C. Turkel | Director | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 09 Feb 2023 | 1,500 | 1,500 | - | 2.8 | 4,267 | Common Shares |
| Lexaria Bioscience Corp | Catherine C. Turkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 1,600 | 5,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Catherine C. Turkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2022 | 3,400 | 3,400 | - | - | Stock Options |